Peginterferon and ribavirin treatment for hepatitis C virus infection

被引：49
|
作者：
Tsubota, Akihito [1 ]
Fujise, Kiyotaka [1 ]
Namiki, Yoshihisa [1 ]
Tada, Norio [1 ]
机构：
[1] Jikei Univ, Sch Med, Inst Clin Med & Res, Chiba 2778567, Japan
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2011年 / 17卷 / 04期
关键词：
Pegylated interferon alpha; Ribavirin; Chronic hepatitis C virus infection; Difficult-to-treat patient; Individualized treatment; Response-guided therapy; Specifically targeted antiviral therapy for hepatitis C virus; ALPHA-2B PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON-ALPHA; CHRONIC HCV INFECTION; RANDOMIZED-TRIAL; HEPATOCELLULAR-CARCINOMA; NAIVE PATIENTS; COMBINATION THERAPY; GENOTYPE-1; PATIENTS; FUSION PROTEIN;
D O I：
10.3748/wjg.v17.i4.419
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Pegylated interferon alpha (IFN alpha) in combination with ribavirin is currently recommended as a standard-of-care treatment for chronic hepatitis C virus (HCV) infection. This combination therapy has drastically improved the rate of sustained virological response, specifically in difficult-to-treat patients. Recently, individualized treatment, such as response-guided therapy, is being developed based on host-, HCV- and treatment-related factors. Furthermore, modified regimens with currently available medications, novel modified IFN alpha and ribavirin or combinations with specifically targeted antiviral therapy for HCV agents, are currently being investigated. The purpose of this review is to address some issues and epoch-making topics in the treatment of chronic HCV infection, and to discuss more optimal and highly individualized therapeutic strategies for HCV-infected patients.
引用
收藏
页码：419 / 432
页数：14
相关论文
共 50 条
  • [31] The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C
    Nunnari, G.
    Montineri, A.
    Portelli, V.
    Savalli, F.
    Fatuzzo, F.
    Cacopardo, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (08) : 1013 - 1016
  • [32] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
  • [33] Peginterferon α-2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single-centre study of 367 cases
    Alavian, Seyed-Moayed
    Tabatabaei, Seyed Vahid
    Keshvari, Maryam
    Behnava, Bita
    Miri, Seyyed Mohammad
    Elizee, Pegah Karimi
    Lankarani, Kamran Bagheri
    LIVER INTERNATIONAL, 2010, 30 (08) : 1173 - 1180
  • [34] Virologic responses and tolerance of peginterferon alfa plus ribavirin treatment for patients with chronic hepatitis C virus infection in different age categories
    Yang, Z.
    Lu, Y.
    Xu, Q.
    Chen, X.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2016, 19 (01) : 133 - 139
  • [35] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Vasily Isakov
    Igor Nikitin
    Vladimir Chulanov
    Pavel Ogurtsov
    Ekaterina Lukyanova
    Jianmin Long
    Janice Wahl
    Frans A Helmond
    the P08160 trial Investigators
    World Journal of Hepatology, 2016, (06) : 331 - 339
  • [36] Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin
    Jacobson, Ira M.
    Marcellin, Patrick
    Zeuzem, Stefan
    Sulkowski, Mark S.
    Esteban, Rafael
    Poordad, Fred
    Bruno, Savino
    Burroughs, Margaret H.
    Pedicone, Lisa D.
    Boparai, Navdeep
    Deng, Weiping
    DiNubile, Mark J.
    Gottesdiener, Keith M.
    Brass, Clifford A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    HEPATOLOGY, 2012, 56 (02) : 567 - 575
  • [37] Results of treatment with peginterferon plus ribavirin in patients with chronic hepatitis C
    Pizarro, Carolina
    Venegas, Mauricio
    Hola, Karen
    Smok, Gladys
    Brahm, Javier
    REVISTA MEDICA DE CHILE, 2011, 139 (06) : 704 - 709
  • [38] Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus
    Gluud, Lise Lotte
    Marchesini, Emanuela
    Iorio, Alfonso
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09): : 2335 - 2341
  • [39] Peginterferon alfa-2a plus ribavirin for hemophilic patients with chronic hepatitis C virus infection in Taiwan
    Lin, Jung-An
    Chen, Yeu-Chin
    Cheng, Shin-Nan
    Chen, Peng-Jen
    Chu, Heng-Cheng
    Hsieh, Tsai-Yuan
    Shih, Yu-Lueng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (10) : 727 - 733
  • [40] Long-Term Follow-Up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection
    Haber, Barbara
    Alonso, Estella
    Pedreira, Alejandra
    Rodriguez-Baez, Norberto
    Ciocca, Mirta
    Lacaille, Florence
    Lang, Thomas
    Gonzalez, Teresita
    Goodman, Zachary
    Yang, Zijiang
    Jackson, Beth
    Noviello, Stephanie
    Albrecht, Janice K.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (01): : 89 - 94
12345